Featured Research

from universities, journals, and other organizations

Progress in the fight against harmful fungi

Date:
August 20, 2014
Source:
Medical University of Vienna
Summary:
One of the world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans, has been developed by researchers. Molecular analysis of the Candida glabrata fungus mutations led to the discovery of 28 new genes that are partly responsible for the yeast's tolerance of common drugs. Infectious diseases caused by fungi, viruses, bacteria and parasites represent the world's number one cause of death. A few dozen types of harmful fungi claim more than 1.5 million human lives every year.

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida glabrata fungus mutations led to the discovery of 28 new genes that are partly responsible for the yeast's tolerance of common drugs.
Credit: Image courtesy of Medical University of Vienna

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida glabrata fungus mutations led to the discovery of 28 new genes that are partly responsible for the yeast's tolerance of common drugs.

Infectious diseases caused by fungi, viruses, bacteria and parasites represent the world's number one cause of death. A few dozen types of harmful fungi claim more than 1.5 million human lives every year. Especially people with a severely weakened immune system are at particular risk of infections with yeasts of the Candida species, with invasive infections being fatal in around 40 per cent of cases. Medications are expensive, and fungi are increasingly developing resistance.

The working group led by Karl Kuchler at the Max F. Perutz Laboratories (MFPL) -- a research and training centre run jointly between the University of Vienna and the Medical University of Vienna at the Vienna Biocenter Campus -- coordinated an international study cooperation aimed at researching new tolerance and virulence genes in Candida glabrata. During this process, genetic methods were used to generate one of the three world's largest libraries of "knock-out fungi." More than 600 fungus mutations were created from which a single gene was specifically removed.

As now published in the journal PLoS Pathogens, the molecular analysis of the Candida glabrata fungus mutations revealed 28 new genes that confer anti-fungal tolerance, especially to the popular drug Caspofungin. The study, in which the coordinators in Vienna also collaborated with groups from the Johns Hopkins University, the Institut Pasteur in Paris, the Fraunhofer Institute in Stuttgart, the Imperial College in London and the Genomics Institute in Barcelona, also identified new intra-cellular stress sensors and signal transmitters in Candida glabrata. Removing these characteristics genetically leads to marked sensitivity to all of the anti-fungal medications currently used in clinical practice -- including Caspofungin.

"Since genetically removing these virulence factors from Candida glabrata patient isolates markedly reduces their virulence as well as dramatically increases the fungal pathogens' sensitivity to medications, these signal transmitters are the best points of attack for the development of new and highly effective anti-fungal therapies," says Karl Kuchler from the MFPL. "These findings represent a new milestone in the discovery and characterisation of Candida glabrata resistance genes, laying the foundations for the development of new anti-fungal medications. This means that, in future, it will be possible to treat the often fatal invasive infections with pathogenic fungi in a more targeted and efficient manner."

Worldwide, more than Euro 8 billion is spent worldwide on anti-fungal medications, and the overall costs of treating the conditions caused by pathogenic fungi exceed hundreds of billions worldwide. The second-most common Candida fungus harmful to humans, Candida glabrata, is a major clinical problem since it has sophisticated natural tolerance and can demonstrate resistance triggered by anti-fungal therapy to the most important medications. As a result, infections with Candida glabrata need to be treated with very expensive drugs such as Caspofungin. Caspofungin blocks the biogenesis of components of the carbohydrate-rich cell wall, which is only found in fungi. The treatment of Candida glabrata, however, is becoming increasingly difficult due to the fact that anti-fungal resistance is common, the costs of Caspofungin are very high and because the frequency of infections with Candida glabrata has increased tremendously.


Story Source:

The above story is based on materials provided by Medical University of Vienna. Note: Materials may be edited for content and length.


Journal Reference:

  1. Tobias Schwarzmüller, Biao Ma, Ekkehard Hiller, Fabian Istel, Michael Tscherner, Sascha Brunke, Lauren Ames, Arnaud Firon, Brian Green, Vitor Cabral, Marina Marcet-Houben, Ilse D. Jacobsen, Jessica Quintin, Katja Seider, Ingrid Frohner, Walter Glaser, Helmut Jungwirth, Sophie Bachellier-Bassi, Murielle Chauvel, Ute Zeidler, Dominique Ferrandon, Toni Gabaldón, Bernhard Hube, Christophe d'Enfert, Steffen Rupp, Brendan Cormack, Ken Haynes, Karl Kuchler. Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes. PLoS Pathogens, 2014; 10 (6): e1004211 DOI: 10.1371/journal.ppat.1004211

Cite This Page:

Medical University of Vienna. "Progress in the fight against harmful fungi." ScienceDaily. ScienceDaily, 20 August 2014. <www.sciencedaily.com/releases/2014/08/140820091303.htm>.
Medical University of Vienna. (2014, August 20). Progress in the fight against harmful fungi. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2014/08/140820091303.htm
Medical University of Vienna. "Progress in the fight against harmful fungi." ScienceDaily. www.sciencedaily.com/releases/2014/08/140820091303.htm (accessed October 23, 2014).

Share This



More Plants & Animals News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Working Mother DIY: Pumpkin Pom-Pom

Working Mother DIY: Pumpkin Pom-Pom

Working Mother (Oct. 22, 2014) — How to make a pumpkin pom-pom. Video provided by Working Mother
Powered by NewsLook.com
Goofy Dinosaur Blends Barney and Jar Jar Binks

Goofy Dinosaur Blends Barney and Jar Jar Binks

AP (Oct. 22, 2014) — A collection of dinosaur bones reveal a creature that is far more weird and goofy-looking than scientists originally thought when they found just the arm bones nearly 50 years ago, according to a new report in the journal Nature. (Oct. 22) Video provided by AP
Powered by NewsLook.com
San Diego Zoo's White Rhinos Provide Hope for the Critically Endangered Species

San Diego Zoo's White Rhinos Provide Hope for the Critically Endangered Species

Reuters - Light News Video Online (Oct. 22, 2014) — The pair of rare white northern rhinos bring hope for their species as only six remain in the world. Elly Park reports. Video provided by Reuters
Powered by NewsLook.com
Raw: Bear Cub Strolls Through Oregon Drug Store

Raw: Bear Cub Strolls Through Oregon Drug Store

AP (Oct. 22, 2014) — Shoppers at an Oregon drug store were surprised by a bear cub scurrying down the aisles this past weekend. (Oct. 22) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins